Eton Pharmaceuticals Inc. monthly returns
Eton Pharmaceuticals Inc. has averaged 3.83% per month, positive in 52% of months. Month-by-month returns for Eton Pharmaceuticals Inc. (ETON) below, through October 20, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Eton Pharmaceuticals Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -2.5% | |
| Sep 2026 | -14.8% | |
| Aug 2026 | +30.2% | |
| Jul 2026 | +28.2% | |
| Jun 2026 | +18.9% | |
| May 2026 | +26.2% | |
| Apr 2026 | -2.3% | |
| Mar 2026 | +45.3% | |
| Feb 2026 | +13.2% | |
| Jan 2026 | -11.2% | |
| Dec 2025 | +4.7% | |
| Nov 2025 | -10.3% | |
| Oct 2025 | -17.1% | |
| Sep 2025 | +25.5% | |
| Aug 2025 | +22.2% | |
| Jul 2025 | -0.6% | |
| Jun 2025 | -24.6% | |
| May 2025 | +12.1% | |
| Apr 2025 | +29.8% | |
| Mar 2025 | -17.3% | |
| Feb 2025 | -11.2% | |
| Jan 2025 | +32.7% | |
| Dec 2024 | -1.6% | |
| Nov 2024 | +59.7% | |
| Oct 2024 | +41.2% | |
| Sep 2024 | +30.4% | |
| Aug 2024 | +27.8% | |
| Jul 2024 | +9.4% | |
| Jun 2024 | -7.3% | |
| May 2024 | +1.4% | |
| Apr 2024 | -6.7% | |
| Mar 2024 | -15.7% | |
| Feb 2024 | -4.7% | |
| Jan 2024 | +6.6% | |
| Dec 2023 | +23.7% | |
| Nov 2023 | -16.1% | |
| Oct 2023 | +1.2% | |
| Sep 2023 | -7.3% | |
| Aug 2023 | +59.6% | |
| Jul 2023 | -19.2% | |
| Jun 2023 | -11.9% | |
| May 2023 | +9.1% | |
| Apr 2023 | -5.7% | |
| Mar 2023 | +3.2% | |
| Feb 2023 | +7.2% | |
| Jan 2023 | +23.4% | |
| Dec 2022 | -6.6% | |
| Nov 2022 | +18.4% | |
| Oct 2022 | +21.4% | |
| Sep 2022 | -7.1% | |
| Aug 2022 | -15.7% | |
| Jul 2022 | +2.3% | |
| Jun 2022 | -13.8% | |
| May 2022 | -13.9% | |
| Apr 2022 | -19.0% | |
| Mar 2022 | +16.0% | |
| Feb 2022 | +1.6% | |
| Jan 2022 | -13.8% | |
| Dec 2021 | +10.0% | |
| Nov 2021 | -32.3% | |
| Oct 2021 | +14.3% | |
| Sep 2021 | -4.4% | |
| Aug 2021 | +2.5% | |
| Jul 2021 | -16.6% | |
| Jun 2021 | -12.7% | |
| May 2021 | -18.7% | |
| Apr 2021 | +18.6% | |
| Mar 2021 | -7.5% | |
| Feb 2021 | -11.3% | |
| Jan 2021 | +9.7% | |
| Dec 2020 | +2.4% | |
| Nov 2020 | +8.9% | |
| Oct 2020 | -7.7% | |
| Sep 2020 | +0.8% | |
| Aug 2020 | +17.4% | |
| Jul 2020 | +22.6% | |
| Jun 2020 | +18.5% | |
| May 2020 | -11.2% | |
| Apr 2020 | +26.3% | |
| Mar 2020 | -24.1% | |
| Feb 2020 | -18.9% | |
| Jan 2020 | -7.5% | |
| Dec 2019 | +12.5% | |
| Nov 2019 | +7.6% | |
| Oct 2019 | -5.9% | |
| Sep 2019 | +13.1% | |
| Aug 2019 | -8.2% | |
| Jul 2019 | -22.9% | |
| Jun 2019 | -2.5% | |
| May 2019 | +10.1% | |
| Apr 2019 | -8.0% | |
| Mar 2019 | +0.8% | |
| Feb 2019 | +30.2% | |
| Jan 2019 | -0.3% | |
| Dec 2018 | -3.6% |
Monthly total return (since Nov 2021)#
Eton Pharmaceuticals Inc. returns by calendar month#
Every month of every year since 2019, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -2.52% — 5th of 8 Octobers since 2019 at the last close; the average October returned +6.8%.
| Month | −60%0+60% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +5.0% | +3.1% | 50% | +32.7% 2025 | -13.8% 2022 | |
| Feb | +0.8% | -1.5% | 50% | +30.2% 2019 | -18.9% 2020 | |
| Mar | +0.1% | -3.4% | 50% | +45.3% 2026 | -24.1% 2020 | |
| Apr | +4.1% | -4.0% | 38% | +29.8% 2025 | -19.0% 2022 | |
| May | +1.9% | +5.3% | 63% | +26.2% 2026 | -18.7% 2021 | |
| Jun | -4.4% | -9.6% | 25% | +18.9% 2026 | -24.6% 2025 | |
| Jul | +0.4% | +0.8% | 50% | +28.2% 2026 | -22.9% 2019 | |
| Aug | +17.0% | +19.8% | 75% | +59.6% 2023 | -15.7% 2022 | |
| Sep | +4.5% | -1.8% | 50% | +30.4% 2024 | -14.8% 2026 | |
| Oct | +6.8% | +1.2% | 57% | +41.2% 2024 | -17.1% 2025 | |
| Nov | +5.1% | +7.6% | 57% | +59.7% 2024 | -32.3% 2021 | |
| Dec | +6.5% | +4.7% | 71% | +23.7% 2023 | -6.6% 2022 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from ETON's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Eton Pharmaceuticals Inc.'s average monthly return?
- Eton Pharmaceuticals Inc. (ETON) has averaged about 3.83% per month, positive in roughly 52% of months. The best month was Nov 2024 (+59.7%) and the worst was Nov 2021 (-32.3%).
